Tamsulosin alters levofloxacin pharmacokinetics in prostates derived from rats with acute bacterial prostatitis

Asian Journal of Andrology

Volumn 15, Issue 2, 2013, Pages 254-260

  Qin, Guo Dong ^a   Xiao, Ming Zhao ^a   Zhou, Yuan Da ^a   Yang, Jing ^a   He, Hai Xia ^a   He, Yue ^a   Zeng, Yang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

1 adrenergic antagonist; antibiotic pharmacokinetics; prostatitis; rats

Indexed keywords

LEVOFLOXACIN; SOLVENT; TAMSULOSIN;

ACUTE BACTERIAL PROSTITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; BLOOD ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG TISSUE LEVEL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PROSTATE; PROSTATITIS; RAT;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG INTERACTIONS; ESCHERICHIA COLI INFECTIONS; KIDNEY; LIVER; MALE; OFLOXACIN; PROSTATE; PROSTATITIS; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 84874631218     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.134     Document Type: Article

References (21)

1. Liang CZ, Li HJ, Wang ZP, Xing JP, Hu WL et al. Treatment of chronic prostatitis in Chinese men. Asian J Androl 2009; 11: 153-6.
2. Kreiger JN, Lee SW, Jeon J, Cheah PY, LiongMLet al. Epidemiology of prostatitis. Int J Antimicrob Agents 2008; 31 (Suppl 1): S85-90.
3. Tripp DA, Nickel JC, Landis JR, Wang YL, Knauss JS et al. Predictor of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: finding from the National Institutes of Health Chronic Prostatitis cohort Study. BJU Int 2004; 9: 1279-82.
4. Nickel JC, Downey J, Ardern D, Clark J, Nickel K. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004; 2: 551-4.
5. Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis 2010; 50: 1641-52.
6. Wagenlehner FM, Weidner W, Naber KG. Therapy for prostatitis, with emphasis on bacterial prostatitis. Expert Opin Pharmacother 2007; 11: 1667-74.
7. Schiller DS, Parikh A. Identification, pharmacologic considerations, and management of prostatitis. Am J Geriatr Pharmacother 2011; 1: 37-48.
8. Yoon BI, Kim S, Han DS, Ha US, Lee SJ et al. Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother 2012; 18: 444-50.
9. Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 2011; 1: 78-86.
10. Ye ZQ, Lan RZ, Yang WM, Yao LF, Yu X. Tamsulosin treatment of chronic non-bacterial prostatitis. J Int Med Res 2008; 2: 244-52.
11. Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC. a-blockers, antibiotics and antiinflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int 2012; 110: 1014-22.
12. Elkahwaji JE, Ott CJ, Janda LM, Hopkins WJ. Mouse model for acute bacterial prostatitis in genetically distinct inbred strains. Urology 2005; 4: 883-7.
13. Quintar AA, Roth FD, de Paul AL, Aoki A, Maldonado CA. Toll-like receptor 4 in rat prostate: modulation by testosterone and acute bacterial infection in epithelial and stromal cell. Biol Reprod 2006; 5: 664-72.
14. de Smet J, Boussery K, Colpaert K, de Sutter P, Decruyenaere J. Pharmacokinetics of fluoroquinolones in critical care patients: a bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 961-7.
15. Srinivas N, Narasu L, Shankar BP, Mullangi R. Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study. Biomed Chromatogr 2008; 11: 1288-95.
16. Krieger JN, Nyberg LJ, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999; 3: 236-7.
17. Etienne M, Chavanet P, Sibert L, Michel F, Levesque H et al. Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 2008; 8: 12.
18. Lee CB, Ha US, Yim SH, Lee HR, Sohn DW et al. Does finasteride have a preventive effect on chronic bacterial prostatitis? Pilot study using an animal model. Urol Int 2011; 2: 204-9.
19. Ha US, Kim ME, Kim CS, Shim BS, Han CH et al. Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Int J Antimicrob Agents 2008; 31 (Suppl 1): S96-101.
20. Naber KG. Management of bacterial prostatitis: what's new? BJU Int 2008; 3: 7-10.
21. Korstanje C, Krauwinkel W, van Doesum-Wolters FL. Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity? Br J Clin Pharmacol 2011; 72: 218-25.